Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LifeMD, Inc. Director's Dealing 2017

Nov 21, 2017

33298_dirs_2017-11-21_3564937a-5885-4d1a-8134-ba7dfc6802d2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: Immudyne, Inc. (IMMD)
CIK: 0000948320
Period of Report: 2017-10-16

Reporting Person: Strawn John R Jr (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, par value $0.01 15000 Direct
Common Stock, par value $0.01 300000 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Option $0.2 2021-12-31 Common Stock, par value $0.01 (1000000) Direct
Option $0.4 2021-12-31 Common Stock, par value $0.01 (500000) Direct
Option $0.4 2017-01-01 Common Stock, par value $0.01 (500000) Direct
Option $0.35 2017-07-01 Common Stock, par value $0.01 (100000) Direct

Footnotes

F1: Mr. Strawn has shared voting and dispositive power.